Numinus Wellness Inc Ordinary Shares NUMIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NUMIF is a good fit for your portfolio.
News
-
Cedar Clinical Research selected as clinical research site for Cybin's Phase 3 Study of CYB003
-
Toronto Stocks Edge Lower; Parkland Shares Up After Rebuffing Call for Strategic Review
-
Numinus Wellness Provides Corporate Update
-
Numinus Wellness Inc. Announces Second Quarter Fiscal 2024 Results
-
Numinus to Host Q2 Fiscal 2024 Results Conference Call on April 15, 2024
-
Numinus Wellness Submits Clinical Trial Application
-
Numinus Wellness Provides Corporate Update
-
Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.05–0.20
- Bid/Ask
- $0.05 / $0.05
- Market Cap
- $16.60 Mil
- Volume/Avg
- 67,085 / 289,117
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.80
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 200
- Website
- https://www.numinus.ca
Valuation
|
Metric
|
NUMIF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.24 |
Price/Sales | 0.80 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NUMIF
|
|---|---|
Quick Ratio | 2.09 |
Current Ratio | 2.47 |
Interest Coverage | −37.20 |
Quick Ratio
NUMIF
Profitability
|
Metric
|
NUMIF
|
|---|---|
Return on Assets (Normalized) | −70.66% |
Return on Equity (Normalized) | −103.38% |
Return on Invested Capital (Normalized) | −74.94% |
Return on Assets
NUMIF
Medical Care Facilities Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
HCA
| HCA Healthcare Inc | Ytsqjxg | Yrtvgns | $80.6 Bil | |
FSNUY
| Fresenius SE & Co KGaA ADR | — | Tjhky | $16.9 Bil | |
FSNUF
| Fresenius SE & Co KGaA | — | Ywyqrhw | $16.9 Bil | |
BDUUY
| Bangkok Dusit Medical Services PCL ADR | — | Ltzx | $12.5 Bil | |
BDUUF
| Bangkok Dusit Medical Services PCL Units Non-Voting Depository Receipt | — | Ctcr | $12.5 Bil | |
JDHIY
| JD Health International Inc ADR | — | Fnngsz | $12.4 Bil | |
FMS
| Fresenius Medical Care AG ADR | Lwtjb | Mjcwgb | $12.4 Bil | |
DVA
| DaVita Inc | Gsszkbz | Qwvhljt | $11.8 Bil | |
THC
| Tenet Healthcare Corp | Tsmgrblgt | Twg | $11.7 Bil | |
AMN
| AMN Healthcare Services Inc | Gzbbkryt | Nxlrfn | $2.3 Bil |